Kenya Yamaguchi Selected Research

Kenya Yamaguchi Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 01/2005
13	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 01/2005
10	Carcinoma (Carcinomatosis) 03/2024 - 09/2005
10	Renal Cell Carcinoma (Grawitz Tumor) 03/2021 - 06/2004
4	Neoplasm Metastasis (Metastasis) 03/2024 - 10/2010
2	Lymphatic Metastasis 03/2024 - 01/2012
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2023 - 12/2013
2	Hyperplasia 11/2022 - 12/2020
2	Kidney Neoplasms (Kidney Cancer) 08/2022 - 06/2004
2	Stress Urinary Incontinence 04/2022 - 03/2014
2	Pelvic Organ Prolapse 12/2021 - 03/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016 - 01/2012
2	Lower Urinary Tract Symptoms 03/2014 - 12/2013
1	Brain Neoplasms (Brain Tumor) 03/2024
1	Postoperative Hemorrhage 12/2021
1	Purpura 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Myalgia 01/2021
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2021
1	Erythema elevatum diutinum 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Pelvic Neoplasms 11/2020
1	Ulcerative Colitis 09/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2020
1	Colitis 09/2020
1	Hematuria 05/2019
1	Adenoma (Adenomas) 05/2019
1	Rectal Diseases (Rectal Disease) 10/2017
1	Hypertension (High Blood Pressure) 09/2017
1	Fistula 01/2017
1	Urinary Incontinence 01/2017
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 12/2016
1	Mumps 04/2014
1	Orchitis 04/2014
1	Infections 04/2014

Drug/Important Bio-Agent (IBA)

6	pembrolizumabIBA 12/2023 - 01/2021
4	AndrogensIBA 04/2023 - 01/2005
3	abirateroneIBA 05/2024 - 02/2020
3	NivolumabIBA 08/2022 - 09/2020
3	Hormones (Hormone)IBA 10/2014 - 01/2005
3	Cytotoxins (Cytolysins)IBA 09/2005 - 06/2004
2	PlatinumIBA 12/2023 - 05/2023
2	Immune Checkpoint InhibitorsIBA 12/2023 - 09/2020
2	Prostate-Specific Antigen (Semenogelase)IBA 10/2023 - 04/2023
2	Flutamide (Eulexin)FDA LinkGeneric 04/2023 - 10/2014
2	Dutasteride (Avodart)FDA Link 11/2022 - 12/2020
2	ErbB Receptors (EGF Receptor)IBA 06/2021 - 09/2017
2	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 09/2020
2	EnzymesIBA 05/2019 - 01/2007
2	PyrrolesIBA 10/2014 - 11/2013
2	imidazoleIBA 10/2014 - 11/2013
2	Nylons (Nylon)IBA 10/2014 - 11/2013
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2013 - 06/2007
2	Proteins (Proteins, Gene)FDA Link 04/2008 - 10/2005
2	Hemoglobin CIBA 04/2008 - 10/2005
2	immunosuppressive acidic proteinIBA 04/2008 - 10/2005
2	Chromogranin AIBA 01/2007 - 09/2005
1	Aldo-Keto Reductase Family 1 Member C3IBA 05/2024
1	Phosphopyruvate Hydratase (Enolase)IBA 03/2024
1	olaparibIBA 03/2024
1	enfortumab vedotinIBA 12/2023
1	SteamIBA 11/2023
1	avelumabIBA 05/2023
1	Gemcitabine FDA Link 05/2023
1	Docetaxel (Taxotere)FDA Link 04/2023
1	Androgen Receptor AntagonistsIBA 04/2023
1	cabazitaxel FDA Link 04/2023
1	enzalutamideIBA 04/2023
1	bicalutamide (Casodex)FDA LinkGeneric 04/2023
1	Taxoids (Taxanes)IBA 04/2023
1	Androgen Receptors (Androgen Receptor)IBA 04/2023
1	Proton Pump InhibitorsIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	AntibodiesIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AlbuminsIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	GlobulinsIBA 01/2021
1	EnbucrilateIBA 11/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	CalciumIBA 09/2017
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2016
1	Mumps Vaccine (Vaccine, Mumps)IBA 04/2014

Therapy/Procedure

11	Therapeutics 11/2023 - 01/2005
4	Castration 05/2024 - 10/2014
4	Radiotherapy 03/2024 - 01/2016
4	Drug Therapy (Chemotherapy) 12/2023 - 01/2012
3	Aftercare (After-Treatment) 04/2023 - 12/2013
1	Combination Drug Therapy (Combination Chemotherapy) 05/2023
1	Immunotherapy 01/2023
1	Sutures (Suture) 12/2021
1	Length of Stay 12/2021
1	Nephrectomy 03/2021
1	Cesarean Section (Caesarean Section) 01/2017
1	Transplantation 12/2016
1	Injections 12/2016
1	Cystectomy 01/2016